文献速递消化道肿瘤与早癌消化内镜

局限性胃体萎缩性胃炎中胃肿瘤性病变的发生率与预测因素:单中心队列研究

Incidence and Predictors of Gastric Neoplastic Lesions in Corpus-Restricted Atrophic Gastritis: A Single-Center Cohort Study.
PubMed 文献 · Am J Gastroenterol · 2023-05-19

该前瞻性单中心队列纳入275例局限性胃体萎缩性胃炎患者,中位随访5年。胃神经内分泌肿瘤1型年发病率为2.8%,所有胃肿瘤性病变为3.9%。年龄>60岁、无假幽门腺化生的肠上皮化生和恶性贫血与高级别上皮内瘤变/胃癌或低级别上皮内瘤变风险升高相关。

要点

  • 局限性胃体萎缩性胃炎患者尽管OLGA分期多为2期,仍面临胃癌和1型胃神经内分泌肿瘤风险。
  • 年龄>60岁、无假幽门腺化生的肠上皮化生及恶性贫血与胃癌/高级别上皮内瘤变或低级别上皮内瘤变风险升高相关。
  • 恶性贫血是1型胃神经内分泌肿瘤的独立危险因素。

核心结论

  • 局限性胃体萎缩性胃炎患者尽管OLGA评分低危,仍有胃癌和1型胃神经内分泌肿瘤风险。
  • 年龄>60岁且伴胃体肠上皮化生或恶性贫血者可能呈现高危场景。

研究设计与样本

  • 前瞻性单中心队列研究,纳入275例遵循内镜-组织学监测的局限性胃体萎缩性胃炎患者。
  • 随访胃镜按胃上皮癌前状态和病变管理指南安排,症状新发或加重时提前行胃镜。
  • 采用Cox回归分析和Kaplan-Meier生存曲线。

主要发现

  • 中位随访5(1-17)年,胃癌/高级别上皮内瘤变、低级别上皮内瘤变、1型胃神经内分泌肿瘤及所有胃肿瘤性病变的年发病率为0.5%、0.6%、2.8%和3.9%。
  • 基线时除2例低级别上皮内瘤变和1例1型胃神经内分泌肿瘤患者为OLGA-1外,其余患者均为OLGA-2。
  • 年龄>60岁(HR 4.7)、无假幽门腺化生的肠上皮化生(HR 4.3)和恶性贫血(HR 4.3)与胃癌/高级别上皮内瘤变或低级别上皮内瘤变风险升高相关,进展平均生存时间分别为13.4、13.2和11.1年 vs 14.7年(P=0.01)。
  • 恶性贫血是1型胃神经内分泌肿瘤的独立危险因素(HR 2.2),与进展平均生存时间缩短相关(11.7 vs 13.6年,P=0.04),并与严重胃体萎缩相关(12.8 vs 13.6年,P=0.03)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Corpus-restricted atrophic gastritis is a chronic inflammatory disorder leading to possible development of type 1 neuroendocrine tumors (T1gNET), intraepithelial neoplasia (IEN), and gastric cancer (GC). We aimed to assess occurrence and predictors of gastric neoplastic lesions in patients with corpus-restricted atrophic gastritis at long-term follow-up. METHODS: A prospective single-center cohort of patients with corpus-restricted atrophic gastritis adhering to endoscopic-histological surveillance was considered. Follow-up gastroscopies were scheduled according to the management of epithelial precancerous conditions and lesions of the stomach guidelines. In case of new/worsening of known symptoms, gastroscopy was anticipated. Cox regression analyses and Kaplan-Meier survival curves were obtained. RESULTS: Two hundred seventy-five patients with corpus-restricted atrophic gastritis (72.0% female, median age 61 [23-84] years) were included. At a median follow-up of 5 (1-17) years, the annual incidence rate person-year was 0.5%, 0.6%, 2.8%, and 3.9% for GC/high-grade IEN, low-grade IEN, T1gNET, and all gastric neoplastic lesions, respectively. All patients showed at baseline operative link for gastritis assessment (OLGA)-2, except 2 low-grade (LG) IEN patients and 1 T1gNET patient with OLGA-1. Age older than 60 years (hazard ratio [HR] 4.7), intestinal metaplasia without pseudopyloric metaplasia (HR 4.3), and pernicious anemia (HR 4.3) were associated with higher risk for GC/HG-IEN or LG-IEN development and shorter mean survival time for progression (13.4, 13.2, and 11.1, respectively, vs 14.7 years, P = 0.01). Pernicious anemia was an independent risk factor for T1gNET (HR 2.2) and associated with a shorter mean survival time for progression (11.7 vs 13.6 years, P = 0.04) as well as severe corpus atrophy (12.8 vs 13.6 years, P = 0.03). DISCUSSION: Patients with corpus-restricted atrophic gastritis are at increased risk for GC and T1gNET despite low-risk OLGA scores, and those aged older than 60 years with corpus intestinal metaplasia or pernicious anemia seem to display a high-risk scenario.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Dilaghi E, Dottori L, Pivetta G, et al. Incidence and Predictors of Gastric Neoplastic Lesions in Corpus-Restricted Atrophic Gastritis: A Single-Center Cohort Study. Am J Gastroenterol. 2023. PMID: 37207305. doi:10.14309/ajg.0000000000002327

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。